One case reported improvement in abnormal respiratory movements after clotiazepam, but did not establish a standard treatment or a general safety advantage.
What the source reports
An eighty-nine-year-old man with vascular parkinsonism developed distressing irregular breathing and orofacial and truncal dyskinesia after an increase in ropinirole treatment. Mirtazapine did not relieve the respiratory symptoms. After clotiazepam was introduced, respiratory and peripheral movements improved markedly within two days.
Limits and uncertainty
The uncontrolled course involved a complex neurological disorder, anxiety and other medications. Natural fluctuation, prior treatment changes and nonspecific anxiolysis could contribute. A short drug half-life is not itself proof of safety in every older adult, and the report cannot establish response frequency or long-term benefit.
Implications for forensic review
For a movement-disorder opinion, document the actual motor phenotype and temporal sequence rather than labeling all dyspnea as respiratory depression. Symptom relief with a benzodiazepine-related drug can have several explanations. The case supports a hypothesis and differential diagnosis, not a patient-independent treatment recommendation.
Source and related reading
Source reviewed: Efficacy of Clotiazepam for Respiratory Dyskinesia in a Patient With Parkinsonism A Case Report (PMC13005727). Forensic applications above are interpretive analysis of the supplied paper.
Related reading: Parkinson’s Disease Benzodiazepine Findings Varied by Cognitive Task.
Leave a Reply